Huadong Medicine Co., Ltd (SHE: 000963)
China
· Delayed Price · Currency is CNY 28.61
-0.11 (-0.38%)
Sep 9, 2024, 1:42 PM CST
Huadong Medicine Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Operating Revenue | 40,836 | 40,261 | 37,489 | 34,418 | 33,604 | 35,378 | Upgrade
|
| Other Revenue | 367.95 | 362.43 | 226 | 145.56 | 78.83 | 67.89 | Upgrade
|
| Revenue | 41,204 | 40,624 | 37,715 | 34,563 | 33,683 | 35,446 | Upgrade
|
| Revenue Growth (YoY) | 3.26% | 7.71% | 9.12% | 2.61% | -4.97% | 15.60% | Upgrade
|
| Cost of Revenue | 27,657 | 27,468 | 25,686 | 23,969 | 22,555 | 24,083 | Upgrade
|
| Gross Profit | 13,546 | 13,156 | 12,028 | 10,595 | 11,128 | 11,363 | Upgrade
|
| Selling, General & Admin | 8,250 | 8,066 | 7,584 | 6,591 | 6,969 | 6,892 | Upgrade
|
| Research & Development | 1,356 | 1,271 | 1,016 | 979.64 | 926.73 | 1,073 | Upgrade
|
| Other Operating Expenses | 226.33 | 203.41 | 205.31 | 176.11 | 184.37 | 180.88 | Upgrade
|
| Operating Expenses | 9,879 | 9,566 | 8,873 | 7,788 | 8,103 | 8,175 | Upgrade
|
| Operating Income | 3,667 | 3,590 | 3,155 | 2,806 | 3,025 | 3,188 | Upgrade
|
| Interest Expense | -115.22 | -114.91 | -120.04 | -68.48 | -68.64 | -107.19 | Upgrade
|
| Interest & Investment Income | 114.17 | 94.05 | 103.35 | 80.4 | 60.99 | 30.59 | Upgrade
|
| Currency Exchange Gain (Loss) | -4.76 | -1.04 | -34.7 | -2.27 | -10.04 | 6.91 | Upgrade
|
| Other Non Operating Income (Expenses) | -5 | -29.65 | -27.16 | -31.93 | -16.68 | 67.05 | Upgrade
|
| EBT Excluding Unusual Items | 3,656 | 3,538 | 3,076 | 2,784 | 2,990 | 3,185 | Upgrade
|
| Impairment of Goodwill | - | - | - | -2.92 | - | - | Upgrade
|
| Gain (Loss) on Sale of Investments | -139.33 | -233.47 | -113.09 | -96.31 | -27.53 | -15.01 | Upgrade
|
| Gain (Loss) on Sale of Assets | 5.73 | 4.32 | 8.26 | -0.03 | 322.64 | 114.15 | Upgrade
|
| Asset Writedown | -0.79 | -5.14 | -5.87 | -5.09 | -2.51 | -4.58 | Upgrade
|
| Other Unusual Items | 207.46 | 161.87 | 65.6 | 147.89 | 170.41 | 190.5 | Upgrade
|
| Pretax Income | 3,729 | 3,466 | 3,031 | 2,828 | 3,453 | 3,470 | Upgrade
|
| Income Tax Expense | 634.65 | 619.59 | 498.5 | 488.91 | 543.67 | 544.86 | Upgrade
|
| Earnings From Continuing Operations | 3,095 | 2,846 | 2,533 | 2,339 | 2,910 | 2,925 | Upgrade
|
| Minority Interest in Earnings | 6.3 | -7.54 | -33.41 | -37 | -89.86 | -112.28 | Upgrade
|
| Net Income | 3,101 | 2,839 | 2,499 | 2,302 | 2,820 | 2,813 | Upgrade
|
| Net Income to Common | 3,101 | 2,839 | 2,499 | 2,302 | 2,820 | 2,813 | Upgrade
|
| Net Income Growth | 19.62% | 13.59% | 8.58% | -18.38% | 0.24% | 24.08% | Upgrade
|
| Shares Outstanding (Basic) | 1,752 | 1,750 | 1,750 | 1,750 | 1,750 | 1,750 | Upgrade
|
| Shares Outstanding (Diluted) | 1,753 | 1,752 | 1,750 | 1,750 | 1,750 | 1,750 | Upgrade
|
| Shares Change (YoY) | 0.15% | 0.11% | 0.00% | -0.00% | 0.00% | -0.44% | Upgrade
|
| EPS (Basic) | 1.77 | 1.62 | 1.43 | 1.32 | 1.61 | 1.61 | Upgrade
|
| EPS (Diluted) | 1.77 | 1.62 | 1.43 | 1.32 | 1.61 | 1.61 | Upgrade
|
| EPS Growth | 19.44% | 13.47% | 8.58% | -18.37% | 0.24% | 24.63% | Upgrade
|
| Free Cash Flow | 2,516 | 2,323 | 1,189 | 2,351 | 1,938 | 648.25 | Upgrade
|
| Free Cash Flow Per Share | 1.44 | 1.33 | 0.68 | 1.34 | 1.11 | 0.37 | Upgrade
|
| Dividend Per Share | 0.930 | 0.580 | 0.290 | 0.290 | 0.230 | 0.280 | Upgrade
|
| Dividend Growth | 220.69% | 100.00% | 0% | 26.09% | -17.86% | 1.82% | Upgrade
|
| Gross Margin | 32.88% | 32.38% | 31.89% | 30.65% | 33.04% | 32.06% | Upgrade
|
| Operating Margin | 8.90% | 8.84% | 8.36% | 8.12% | 8.98% | 8.99% | Upgrade
|
| Profit Margin | 7.53% | 6.99% | 6.63% | 6.66% | 8.37% | 7.94% | Upgrade
|
| Free Cash Flow Margin | 6.11% | 5.72% | 3.15% | 6.80% | 5.76% | 1.83% | Upgrade
|
| EBITDA | 4,411 | 4,303 | 3,778 | 3,316 | 3,456 | 3,592 | Upgrade
|
| EBITDA Margin | 10.70% | 10.59% | 10.02% | 9.59% | 10.26% | 10.13% | Upgrade
|
| D&A For EBITDA | 743.36 | 713.53 | 622.73 | 509.65 | 431 | 404.48 | Upgrade
|
| EBIT | 3,667 | 3,590 | 3,155 | 2,806 | 3,025 | 3,188 | Upgrade
|
| EBIT Margin | 8.90% | 8.84% | 8.36% | 8.12% | 8.98% | 8.99% | Upgrade
|
| Effective Tax Rate | 17.02% | 17.88% | 16.45% | 17.29% | 15.74% | 15.70% | Upgrade
|
| Revenue as Reported | 41,204 | 40,624 | 37,715 | 34,563 | 33,683 | 35,446 | Upgrade
|
| Advertising Expenses | - | - | - | - | - | 24.09 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.